AI-Designed GLP-1 Peptides Outperform Semaglutide
ImmunoPrecise’s AI-designed GLP-1 peptides show superior receptor activation to Semaglutide, signaling a major leap in AI-driven drug discovery.
BrainFreeze Unveils Granular AI Safety for Schools
Airia upgrades BrainFreeze with flexible AI safeguards, enabling secure, role-based protections tailored to diverse educational needs.